Open AccessNoninvasive estimation of liver fibrosis and response to interferon therapy by a serum fibrogenesis marker, YKL-40, in patients with HCV-associated liver disease
Author(s) -
Yukiko Saitou
Publication year - 2005
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v11.i4.476
Subject(s) - fibrosis , medicine , gastroenterology , liver biopsy , procollagen peptidase , hyaluronic acid , hepatic fibrosis , receiver operating characteristic , pathology , biopsy , anatomy
To evaluate the clinical utility of serum fibrosis markers, including YKL-40, in patients with HCV-associated liver disease.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom